clinical trial · NCT05673018
Galleri® in the Medicare Population.
GRAIL, Inc.·N/A·recruiting·n = 50,000
CancerMulti-Cancer Early Detection Test (Galleri®)
brief summary
This multi-center comparative prospective cohort study is designed to assess the real world clinical impact, including safety and test performance, of Galleri®, a blood-based multi-cancer early detection (MCED) test. The study will seek enrollment that is representative of the Medicare population.
started
Jul 12, 2024
primary completion
Sep 1, 2030
completion
Sep 1, 2030
last updated
Feb 10, 2026
official title
REACH Study: Galleri® in the Medicare Population.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol